AMPA receptor-mediated slow neuronal death in the rat spinal cord induced by long-term blockade of glutamate transporters with THA

Brain Research

Volumn 771, Issue 1, 1997, Pages 37-44

  Hirata, Akira ^a   Nakamura, Ryohji ^a   Kwak, Shin ^b   Nagata, Naokazu ^a   Kamakura, Keiko ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Tokyo Medical and Dental University   (Japan)

Author keywords

1 Amino 3 hydroxy 5 methyl 4 isoxazole propionic acid (AMPA) receptor; Amyotrophic lateral sclerosis; DL Threo hydroxyaspartate; Excitatory amino acid; Glutamate; Glutamate transporter; Neurotoxicity; Spinal cord

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 3 HYDROXYASPARTIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR; CARRIER PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; QUISQUALIC ACID;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLIOSIS; LUMBOSACRAL SPINE; MALE; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; OSMOTIC MINIPUMP; PARALYSIS; PRIORITY JOURNAL; RAT; SPINAL CORD; SPINAL CORD DORSAL HORN; SUBARACHNOID SPACE; URINE INCONTINENCE;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; ASPARTIC ACID; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CELL DEATH; GLUTAMIC ACID; HINDLIMB; INFUSIONS, PARENTERAL; INJECTIONS, SPINAL; MALE; MOTOR ACTIVITY; NEURONS; PARALYSIS; RATS; RATS, WISTAR; RECEPTORS, AMPA; SPINAL CORD; SUBARACHNOID SPACE; TAIL; TIME FACTORS; URINARY INCONTINENCE;

EID: 0030724075     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00709-9     Document Type: Article

References (33)

1. Arriza J.L., Fairman W.A., Wadiche J.I., Murdoch G.H., Kavanaugh M.P., Amara S.G. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci. 14:1994;5559-5569.
2. Battaglioli G., Martin D., Plummer J., Messer A. Synaptosomal glutamate uptake declines progressively in the spinal cord of a mutant mouse with motor neuron disease. J. Neurochem. 60:1993;1567-1570.
3. Chase R.A., Pearson S., Nunn P.B., Lantos P.L. Comparative toxicities of α- and β-N-oxalyl-L-α,β-diaminopropionic acids to rat spinal cord. Neurosci. Lett. 55:1985;89-94.
4. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
5. Couratier P., Hugon J., Sindou P., Vallet J.M., Dumas M. Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors. Lancet. 341:1993;265-268.
6. Furuyama T., Kiyama H., Sato K., Park H.T., Maeno H., Takagi H., Tohyama M. Region-specific expression of subunits of ionotrophic glutamate receptors (AMPA-type, KA-type and NMDA receptors) in the rat spinal cord with special reference to nociception. Mol. Brain Res. 18:1993;141-151.
7. Hugon J., Vallat J.M., Spencer P.S., Leboutet M.J., Barthe D. Kainic acid induces early and delayed degenerative neuronal changes in rat spinal cord. Neurosci. Lett. 104:1989;258-262.
8. Ishida M., Shinozaki H. Acromelic acid is a much more potent excitant than kainic acid or domoic acid in the isolated rat spinal cord. Brain Res. 474:1988;386-389.
9. Kanai Y., Hediger M.A. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature. 360:1992;467-471.
10. 3H]AMPA binding sites. Neurosci. Lett. 139:1992;114-117.
11. Kwak S., Aizawa H., Ishida M., Shinozaki H. Acromelic acid, a novel kainate analogue, induces long-lasting paraparesis with selective degeneration of interneurons in the rat spinal cord. Exp. Neurol. 116:1992;145-155.
12. Kwak S., Nakamura R. Selective degeneration of inhibitory interneurons in the rat spinal cord induced by intrathecal infusion of acromelic acid. Brain Res. 702:1995;61-71.
13. Kwak S., Nakamura R. Acute and late neurotoxicity in the rat spinal cord in vivo induced by glutamate receptor agonists. J. Neurol. Sci. 129(Suppl.):1995;99-103.
14. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurological disorders. N. Engl. J. Med. 330:1994;613-622.
15. Mangano R.M., Schwarcz R. Chronic infusion of endogenous excitatory amino acids into rat striatum and hippocampus. Brain Res. Bull. 10:1983;47-51.
16. McBean G.J., Roberts P.J. Neurotoxicity of L-glutamate and DL-threo-3-hydroxyaspartate in the rat striatum. J. Neurochem. 44:1985;247-254.
17. McDonald J.W., Johnston M.V. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res. Rev. 15:1990;41-70.
18. Mitchell J.J., Kevin J.A. Quantitative autoradiographic analysis of excitatory amino acid receptors in the cat spinal cord. Neurosci. Lett. 124:1991;269-272.
19. Nag S., Riopelle R.J. Spinal neuronal pathology associated with continuous intrathecal infusion of N-methyl-aspartate in the rat. Acta Neuropathol. 81:1990;7-13.
20. Nakamura R., Kamakura K., Kwak S. Late-onset selective neuronal damage in the rat spinal cord induced by continuous intrathecal administration of AMPA. Brain Res. 654:1994;279-285.
21. Nalder J.V., Evenson D.A., Cuthbertson G.J. Comparative toxicity of kainic acid and other acidic amino acids towards rat hippocampal neurons. Neuroscience. 12:1981;2505-2517.
22. Pines G., Danbolt N.C., Bjorås M., Zhang Y., Bendahan A., Eide L., Koepsell H., Storm-Mathisen J., Seeberg E., Kanner B.I. Cloning and expression of a rat brain L-glutamate transporter. Nature. 360:1992;464-467.
23. Roberts P.J., Foster G.A., Thomas E.M. Neurotoxic action of methyltetrahydrofolate in rat cerebellum unrelated to direct activation of kainate receptors. Nature. 293:1981;654-655.
24. Rothstein J.D., Martin L.J., Kuncl R.W. Decreased glutamate transporter by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326:1992;1464-1468.
25. Rothstein J.D., Jin L., Dykes-Hoberg M., Kuncl R.W. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. USA. 90:1993;6591-6595.
26. Rothstein J.D., Kammen M.V., Levey A.I., Martin L.J., Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38:1995;73-84.
27. Schwarcz R., Scholz D., Coyle J.T. Structure-activity relations for the neurotoxicity of kainic acid derivatives and glutamate analogues. Neuropharmacology. 17:1978;145-151.
28. 3H]D-Aspartate binding sites in the normal human spinal cord and changes in motor neuron disease: a quantitative autoradiographic study. Brain Res. 655:1994;195-201.
29. Shinozaki H., Ishida M., Gotoh Y., Kwak S. Specific lesions of rat interneurons induced by systemic administration of acromelic acid, a new potent kainate analogue. Brain Res. 503:1989;330-333.
30. Spencer P.S., Roy D.N., Ludolph A.C., Hugon J., Dwived M.P., Schaumburg H.H. Lathyrism: evidence for role of the neuroexcitatory amino acid BOAA. Lancet. 2:1986;1066-1067.
31. Spencer P.S., Nunn P.B., Hugon J., Ludolph A.C., Ross S.M., Roy D.N., Robertson R.C. Guam-amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science. 237:1987;517-522.
32. +-dependent glutamate/aspartate transporter from rat brain. Proc. Natl. Acad. Sci. USA. 89:1992;10955-10959.
33. Urca G., Urca R. Neurotoxic effects of excitatory amino acids in the mouse spinal cord: quisqualate and kainate but not N-methyl-D-aspartate induce permanent neural damage. Brain Res. 529:1990;7-15.